Recognizing and treating two types of long-term vasoconstriction in hypertension

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Pharmacology

Background:

• Essential hypertension, once viewed as a single entity, is now understood as a heterogeneous condition.
• Clinical, pharmacologic, and biochemical evidence reveals distinct pathophysiologic disturbances.
• Two primary mechanisms of long-term vasoconstriction contribute to hypertension.

Purpose of the Study:

• To identify and quantify two distinct vasoconstriction mechanisms in essential hypertension.
• To elucidate the roles of renin-angiotensin system, sodium balance, and calcium in vasoconstriction.
• To provide a framework for pathophysiologic stratification and rational therapeutic targeting in hypertension.

Main Methods:

• Assessment of plasma renin levels to differentiate vasoconstrictor mechanisms.
• Evaluation of hypotensive responses to renin-system targeting drugs (e.g., CEI inhibitors, beta blockers).
• Analysis of serum ionized calcium levels and response to sodium depletion or alpha-adrenergic blockade.

Main Results:

• Renin-angiotensin mediated vasoconstriction involves intracellular calcium mobilization, assessed by plasma renin levels and drug response.
• Renin-independent vasoconstriction is linked to renal sodium retention, abnormal calcium influx, low plasma renin, and low serum ionized calcium.
• Both mechanisms contribute to arteriolar tone, with one predominating at extreme renin levels and potentially both in intermediate ranges.

Conclusions:

• Essential hypertension is characterized by at least two distinct vasoconstrictor mechanisms.
• These mechanisms involve differential regulation of vascular smooth muscle intracellular calcium and are influenced by sodium balance.
• Understanding these pathways allows for more specific and rational therapeutic strategies for hypertension management.